| Trial ID: | L4919 |
| Source ID: | NCT00991055
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: The change from baseline in HbA1Cand FPG, Week 12 | Secondary: Insulin resistance (HOMA-IR index), Week 12
|
| Sponsor/Collaborators: |
Sponsor: National Cheng-Kung University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2010-10
|
| Results First Posted: |
|
| Last Update Posted: |
2009-10-07
|
| Locations: |
National Cheng Kung University Hospital, Tainan, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT00991055
|
